The same group further knocked out METTL3 and found that it activated p-p38 and p-ERK in CRC, whereas the use of p38 or ERK inhibitors markedly reversed the decreased expression of METTL3 induced the migration and invasion of CRC cells (51). The gene discussed is METTL3; the disease is colorectal carcinoma.